Pneumococcal conjugate second or third-dose vaccines (PCVc) in Uganda
Uganda: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 97.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Uganda, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Uganda is 97.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 3.2% on the previous year and up 51.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Uganda peaked at 97.0% in 2025 and was at its lowest, 0.0%, in 2008.
Uganda ranks 17th of 194 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Uganda, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 60.0% | — |
| 2015 | 64.0% | +6.7% |
| 2016 | 77.0% | +20.3% |
| 2017 | 90.0% | +16.9% |
| 2018 | 92.0% | +2.2% |
| 2019 | 92.0% | +0.0% |
| 2020 | 89.0% | -3.3% |
| 2021 | 91.0% | +2.2% |
| 2022 | 90.0% | -1.1% |
| 2023 | 91.0% | +1.1% |
| 2024 | 94.0% | +3.3% |
| 2025 | 97.0% | +3.2% |
Uganda compared with similar countries
- Uganda's 97.0% is above the median for low income countries, which is 80.0%, 1.2× the median. (25 countries reporting)
- Uganda's 97.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 47.5% | 0.0% | 92.0% | 10 |
| 2020s | 92.0% | 89.0% | 97.0% | 6 |
Countries ranked near Uganda
More health data for Uganda
- Un projection of annual infant deaths, annual growth rate -2.2 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.34 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 853.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6,666 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 111 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0787 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Uganda?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Uganda was 97.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Uganda?
- The highest recorded value was 97.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Uganda?
- The lowest recorded value was 0.0% in 2008.
- How does Uganda rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Uganda ranks 17th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Uganda?
- Over the last ten years it is up 51.6%. The long-run trend across the full record is volatile.
- Where does this Uganda data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).